VIRTUAL MEETINGS

Book video meetings with your future collaborators, global leaders most relevant to your working life, using the GCI Networking Platform.

TAILORED CONTENT

Our curated multi-topic program gives you the freedom to choose sessions, hear from thought leaders, and deepen your knowledge on subjects pertinent to you.

JOIN A GLOBAL NETWORK

Leaders across the global cannabis and psychedelics value-chain participate at the GCI Virtual Summit. We work with the best minds, so you can work with them as well.

VIRTUAL MEETINGS

Book video meetings with your future collaborators, global leaders most relevant to your working life, using the GCI Network Platform.

TAILORED CONTENT

Our curated multi-topic program gives you the freedom to choose sessions, hear from thought leaders, and deepen your knowledge on subjects pertinent to you.

JOIN A GLOBAL NETWORK

Leaders across the global cannabis and psychedelics value-chain participate at the GCI Virtual Summit. We work with the best minds, so you can work with them as well.

KEY THEMES

RESEARCH
& APPLIED
SCIENCE

View all

Whilst many of these amazing plant medicines continue to await descheduling from being deemed ‘dangerous, narcotic drugs’ – which will create an easier path for researchers to further examine the therapeutic properties of cannabis and psychedelic compounds – we continue to see huge pre-clinical and clinical breakthroughs around the world, strengthening the reams of observational evidence collected from patients over decades. A lack of pre-existing clinical data has stymied the route to commercialisation for many medicines; however, since the COVID vaccines have been rolled out on the back of real-world data, this potentially paves the way for additional new medicines following a similar path. Join this conference to learn from the pioneers at the forefront of pre-clinical and clinical research, the disease states that show the most promise to being remediated by plant medicines, novel innovations being developed in the lab, and the pharmacology of these magnificent plants.

MEDICINE,
TREATMENT
& PATIENTS

View all

Meet the clinicians prescribing cannabis medicines, clinics using ketamine off-label and patients whose lives have been transformed by plant medicine. Join our thought leaders who will be giving insight into how they treat particular illnesses, recommend products, and embark on educational programmes for both patients and fellow doctors alike.

PSYCHEDELIC THERAPEUTIC COMPOUNDS

View all

The psychedelic industry is growing at breakneck speed, built on the back of tremendous clinical breakthroughs and the growing prominence of psychedelic-assisted therapies. Increasingly, studies on well-known compounds – such as MDMA, LSD, Ayahuasca, Psilocybin – have paved the way for the biggest breakthroughs in mental health for a generation, with innovative organisations developing additional novel compounds to tackle traditionally treatment-resistant conditions. Join this conference to learn about the latest research developments, innovative businesses, investment opportunities, patient access, ceremonial rituals and the psychedelic pioneers that the industry is built upon.

REGULATIONS &
INTERNATIONAL
MARKETS

View all

With a plethora of differing regulatory regimes and an ever-changing policy landscape – even across trading blocks, like the EU – find out how best to operate internationally, meet local partners suitable for your organisation, and glean the key info that will keep you compliant.

RESEARCH & APPLIED SCIENCE

View all

Whilst many of these amazing plant medicines continue to await descheduling from being deemed ‘dangerous, narcotic drugs’ – which will create an easier path for researchers to further examine the therapeutic properties of cannabis and psychedelic compounds – we continue to see huge pre-clinical and clinical breakthroughs around the world, strengthening the reams of observational evidence collected from patients over decades. A lack of pre-existing clinical data has stymied the route to commercialisation for many medicines; however, since the COVID vaccines have been rolled out on the back of real-world data, this potentially paves the way for additional new medicines following a similar path. Join this conference to learn from the pioneers at the forefront of pre-clinical and clinical research, the disease states that show the most promise to being remediated by plant medicines, novel innovations being developed in the lab, and the pharmacology of these magnificent plants.

MEDICINE, TREATMENT & PATIENTS

View all

Meet the clinicians prescribing cannabis medicines, clinics using ketamine off-label and patients whose lives have been transformed by plant medicine. Join our thought leaders who will be giving insight into how they treat particular illnesses, recommend products, and embark on educational programmes for both patients and fellow doctors alike.

PSYCHEDELIC THERAPEUTIC COMPOUNDS

View all

The psychedelic industry is growing at breakneck speed, built on the back of tremendous clinical breakthroughs and the growing prominence of psychedelic-assisted therapies. Increasingly, studies on well-known compounds – such as MDMA, LSD, Ayahuasca, Psilocybin – have paved the way for the biggest breakthroughs in mental health for a generation, with innovative organisations developing additional novel compounds to tackle traditionally treatment-resistant conditions. Join this conference to learn about the latest research developments, innovative businesses, investment opportunities, patient access, ceremonial rituals and the psychedelic pioneers that the industry is built upon.

REGULATIONS & INTERNATIONAL MARKETS

View all

With a plethora of differing regulatory regimes and an ever-changing policy landscape – even across trading blocks, like the EU – find out how best to operate internationally, meet local partners suitable for your organisation, and glean the key info that will keep you compliant.

CONSUMER BRANDS & RETAIL

View all

As the retail landscape was turned on its head by the global pandemic, there’s never been a more significant moment for consumer brands. Having to contend with ever-changing regulations, the fall of brick-and-mortar retail, supply chain breakdowns, and the necessity for a robust, digital presence, many brands have had a sink-or-swim moment. Those who have been able to navigate the tide are well placed to thrive as the world comes back to ‘normal’. Join this conference to learn about product development innovations, branding marketing strategies, best practice for engaging with retailers, and expanding operations cross-border.

CULTIVATION, OPS & TECH

View all

Discover the latest cultivation techniques enabling LPs and boutique growers to optimise their outdoor, indoor and hybrid grow operations to boost sales. Moreover, explore how organisations are utilising tech to automate processes to ensure consistent and stable production.

INVESTMENT & FINANCE

View all

Despite the COVID pandemic, 2020 saw an exponential increase in both private and public investment activity, across both cannabis and psychedelics. This trend has gone into overdrive in 2021, with record numbers of businesses listing publicly and retail investors increasingly able to have exposure to the markets. Much of this has been driven by regulatory and governmental changes, giving investors further confidence that the winds are blowing in the right direction. Join this conference to learn from industry analysts, investment houses and leading business giving insights on deploying capital, navigating regulations, and discussing what’s hot, what’s not and what’s next.

CONSUMER BRANDS & RETAIL

View all

As the retail landscape was turned on its head by the global pandemic, there’s never been a more significant moment for consumer brands. Having to contend with ever-changing regulations, the fall of brick-and-mortar retail, supply chain breakdowns, and the necessity for a robust, digital presence, many brands have had a sink-or-swim moment. Those who have been able to navigate the tide are well placed to thrive as the world comes back to ‘normal’. Join this conference to learn about product development innovations, branding marketing strategies, best practice for engaging with retailers, and expanding operations cross-border.

CULTIVATION, OPERATIONS & TECH

View all

Discover the latest cultivation techniques enabling LPs and boutique growers to optimise their outdoor, indoor and hybrid grow operations to boost sales. Moreover, explore how organisations are utilising tech to automate processes, to ensure consistent and stable production.

INVESTMENT & FINANCE

View all

Despite the COVID pandemic, 2020 saw an exponential increase in both private and public investment activity, across both cannabis and psychedelics. This trend has gone into overdrive in 2021, with record numbers of businesses listing publicly and retail investors increasingly able to have exposure to the markets. Much of this has been driven by regulatory and governmental changes, giving investors further confidence that the winds are blowing in the right direction. Join this conference to learn from industry analysts, investment houses and leading business giving insights on deploying capital, navigating regulations, and discussing what’s hot, what’s not and what’s next.

WANT TO JOIN YOUR GLOBAL PEERS?
SECURE YOUR TICKET TODAY

GET YOUR TICKET FOR THE SUMMIT

Probably the most well executed remote event I have participated in. Truly top notch!

FounderFOCUS

I gained greater insights into Ketamine practice and application, and also to the utilization of other agents, such as psilocybin. My interest has been piqued and I continue to research these topics and engage with the thought leaders that I met during the Summit.

SpecialistKetamine Clinics

Cannabis is a disruptive and innovative industry and GCI mirrors this; they did a tremendous job of putting together relevant topics with experts around the world, in an innovative and new way of making events. This is not a simple task and GCI ran an impeccable Summit with an excellent turn out.

Board MemberColombian-Canadian Chamber of Commerce

The GCI Summit has a world of experts at your fingertips. It often highlights the information you need to know next, before you know it.

Executive DirectorAFDO

I would like to congratulate and thank the organizers of the GCI Summit 2020 for putting together such an excellent virtual cannabinoid conference. It (1) provided a lot of important information and (2) addressed many important issues about cannabis and cannabinoids.

Emeritus ProfessorUniversity of Aberdeen

I think what I really liked most about the Summit was the truly international ‘feel’ to it. The ability to contact and learn from leaders from all over the world had many benefits, over even ‘live events’.

FounderMAMAKA

For Innovators in Cannabis & Psychedelics

The GCI Summit is an event like no other. Our unrivalled, collaborative format enables leaders, like you, to learn from global experts and have high-value conversations with your future partners in a relaxed, professional environment.

Join Global Leaders at the Summit